Description
Cagrilintide 5mg + Semaglutide 5mg 10mg × 10 vials
PeptideHaus presents Cagrilintide 5mg + Semaglutide 5mg 10mg × 10 Vials as part of the
Weight Management Peptides catalogue. This page is structured to make
product identification, documentation access, ordering information and buyer support
easier to review.
Product Information
| Product | Cagrilintide 5mg + Semaglutide 5mg 10mg × 10 vials |
|---|---|
| Catalogue | Weight Management Peptides |
| SKU | CS10 |
| format | As stated in the product title and current catalog listing |
PeptideHouse Buyer Support
Lab / COA Access
Review available documentation through the PeptideHaus Lab / COA information routes.
European Ordering
Shipping and delivery guidance is available for Germany and supported European destinations.
Secure Checkout
Use the current checkout options displayed by PeptideHaus when placing an order.
Wholesale Support
For larger quantities, repeat purchasing or reseller inquiries, use the dedicated wholesale route.
Before Ordering
Review the current product title, catalog image, price, availability and any
product-specific information shown on this page before completing your order.
For documentation, shipping, payment or wholesale questions, contact PeptideHaus support.
Research & Professional Use Notice
Product information on PeptideHaus is provided for catalogue, research-supply and
professional purchasing contexts appropriate to the listed item. PeptideHaus does not
provide medical advice, diagnosis, treatment recommendations or dosage instructions.
Buyers are responsible for ensuring that purchase, possession and intended use comply
with applicable requirements in their jurisdiction.
Cagrilintide 5mg + Semaglutide 5mg 10mg × 10 Vials
Research Compound Overview
This combination represents two investigational peptides used exclusively in laboratory research settings. Cagrilintide is an amylin receptor agonist currently undergoing clinical development for metabolic research applications. Semaglutide, a GLP-1 receptor agonist, is widely studied for weight management and glucose regulation in research contexts.
Key Specifications
- Cagrilintide dosage: 5mg per vial across 10-vial package
- Semaglutide dosage: 5mg and 10mg formulations available
- Total quantity: 10 vials per package
- Research application: Metabolic and weight management studies
Critical Compliance Information
These compounds are strictly for laboratory research use only and are not approved for human consumption. Possession requires proper institutional licensing and regulatory authorization. Unauthorized distribution or human use violates pharmaceutical regulations across most jurisdictions, including Australia and the United States.
Storage and Handling
Maintain proper refrigeration (2-8°C), protect from light, and follow institutional protocols for research compound handling and disposal.










Reviews
There are no reviews yet.